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Abstract
Disruption of dopamine homeostasis may lead to dopaminergic neuron degeneration, a proposed explanation for the
specific vulnerability of dopaminergic neurons in Parkinson’s disease. While expression of human a-synuclein in C. elegans
results in dopaminergic neuron degeneration, the effects of a-synuclein on dopamine homeostasis and its contribution to
dopaminergic neuron degeneration in C. elegans have not been reported. Here, we examined the effects of a-synuclein
overexpression on worm dopamine homeostasis. We found that a-synuclein expression results in upregulation of dopamine
synthesis and content, and redistribution of dopaminergic synaptic vesicles, which significantly contribute to dopaminergic
neuron degeneration. These results provide in vivo evidence supporting a critical role for dopamine homeostasis in
supporting dopaminergic neuron integrity.
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Introduction
Abnormal dopamine (DA) metabolism, which produces reactive
oxygen species (ROS), may lead to dopaminergic (DAergic)
neuron degeneration and has been proposed to be related to the
pathogenesis of Parkinson’s Disease (PD) [1–6]. For example,
overexpression of tyrosine hydroxylase (TH) in primary neuronal
cultures of Drosophila embryos induces cellular degeneration [1]
and vesicular monoamine transporter (VMAT) loss-of-function
mice show nigrostriatal neurogdegeneration [2].
Some in vitro or ex vivo evidence also suggests a connection
between dopamine homeostasis and a-synuclein, the central player
of PD pathology [3–11]. Thus, expression of pathogenic a-
synuclein mutants enhances cytosolic catecholamine levels in
human mesencephalic cells, PC12 cells and mouse chromaffin cells
[12,13]. Moreover, genetic disruption of vesicular dopamine
storage induces age-dependent alterations in the nigrostriatal
dopamine system and progressive nigral cell loss in a-synuclein
positive, but not in a-synuclein negative mice [2]. Reduction of
cytosolic dopamine content either genetically or pharmacologically
prevents haSyn-mediated neuronal degeneration in vitro [1]. It also
has been suggested that a-synuclein overexpression disrupts
vesicular pH, leading to the increased cytosolic catechol species
[13].
Genetic model organisms such as yeast, Drosophila and C. elegans
are valuable surrogates for the study of certain aspects of
neurodegenerative diseases, including investigations of a-synuclein
toxicity [5,14–22]. For example, genes involved in protein
trafficking have recently been identified to be involved in a-
synuclein toxicity, leading to the hypothesis that a-synuclein
mediated altered intracellular trafficking regulates dopamine
homeostasis [5].
Expression of human a-synuclein (haSyn) in DAergic neurons
of C. elegans results in their degeneration [21,22]. Yet, the effects of
haSyn expression on dopamine homeostasis have not been
addressed in this useful organism. Here, we used haSyn-expressing
C. elegans lines to examine the toxic effects of haSyn on dopamine
homeostasis and its contribution to haSyn-mediated DAergic
neuron degeneration.
Results
haSyn Expression Induces DAergic Neuron Degeneration
We first characterized the expression of dat-1 promoter-driven
haSyn by using immunohistochemistry and confocal microscopy.
Positive haSyn immunostaining was found exclusively in DAergic
neurons, marked with dat-1 promoter-driven DsRed, demonstrating
the specificity of haSyn expression in our transgenic lines (Figure S1).
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Previous efforts to express wild type or pathogenic haSyn in worms
led to loss of the fluorescent DAergic neuron marker due to
degeneration of DAergic neurons [5,20]. Consistent with these reports,
our haSyn-expressing line, but not the control line, displayed an age-
related progressive decline in the number of fluorescent DAergic
neurons (Figure 1A–E). Another haSyn-expressing line also exhibited a
similar decline in the number of fluorescent DAergic neurons (data not
shown). This conclusion was further confirmed by TH immunostaining
experiments (Figure S2) and similar experiments where both a non-
functional CAT-2/TH::GFP fusion protein [23,24] and DsRed were
used as DAergic neuron markers (Figure S3).
We next investigated the effect of haSyn expression on the
function of worm DAergic neurons by measuring the basal slowing
response, a food-sensing behavior regulated by dopamine
neurotransmission [25]. The worm basal slowing response was
used to assess the effect of haSyn expression on the function of
DAergic neurons [21]. As found in cat-2, a knockout mutant of
worm TH, haSyn-expressing worms had an impaired basal
slowing response, which returned to control levels in the presence
of 0.5 mM exogenous dopamine (Figure 1F). Thus, animals of the
haSyn expressing line were functionally deficient in dopamine.
Consistent with our haSyn expression pattern, the enhanced
slowing response, a food response behavior regulated by serotonin
neurotransmission [25], was not affected in haSyn expressing
animals (Figure S4).
Taken together, these results lead us to conclude that haSyn
expression induces degeneration of DAergic neurons in our haSyn
expressing lines, similar to previous reports.
haSyn Expression Induces a Motor Capacity Deficit
We next quantified the effect of haSyn expression on worm
motor capacity, which had not been assessed previously in worms
Figure 1. haSyn expression leads to DAergic neuron degeneration. A–D, Confocal images of living day 10 adult control (AB) or haSyn-
expressing (CD) worms with DAergic neuron specific expression of DsRed. A and C, Bright field; B and D, DsRed. E, Number of fluorescent DAergic
neurons in haSyn-expressing (squares) and control (circles) lines. ***, p,0.005 (two-way ANOVA). Error bars represent the SEM (standard error of the
mean) for three independent experiments. In each experiment, the n of each sample varied from 20 to 50. F, Basal slowing response of day 2 adult
worms. TH/CAT-2 KO or cat-2 is a TH/CAT-2 knockout (KO) worm line. GFP indicates a wild type line expressing GFP in DAergic neurons. Food
response experiments were conducted with (grey bars) or without (black bars) food. ***, p,0.0001 (t-test); n varied from 6 to 20. Error bars indicate
SEM.
doi:10.1371/journal.pone.0009312.g001
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specifically expressing haSyn in DAergic neurons [5,21]. In
general, there are two methods to access motor capacity in worms:
body bending frequency and centroid velocity [25–28]. Body
bending frequency is the number of sinusoidal waves made by a
worm during a given time period, while centroid velocity
quantifies the physical displacement of a worm’s centroid. Body
bending frequency can be uncoupled from centroid displacement
by genetic mutations and ageing [26,29]. We observed that L4 and
day 1 adult worms exhibit similar body bending frequencies,
although adult worms move much faster than L4 worms, as
quantified by their centroid velocity (Cao and Feng, unpublished
data). Because the centroid velocity of worm locomotion has been
utilized to quantify age-related changes in motor capacity and
provides more sensitive and reliable quantification of worm motor
activity [26,27], this parameter was selected to address the effect of
haSyn expression on the worm motor system. Indeed, haSyn
expressing worms exhibited a deficit in motor activity that was
restored by adding 1 mM dopamine (Figure 2), a finding
consistent with observations in a Drosophila PD model [17].
haSyn Expression Results in Altered Dopamine
Metabolism
Despite their functional deficiency in dopamine neurotransmis-
sion, haSyn expressing worms surprisingly exhibited a remarkable
upregulation of dopamine content from L4 to day 4 in adulthood
(Figure 3A), as measured by liquid chromatography-mass
spectrometry (LC-MS). We obtained similar results and reached
the same conclusion (data not shown) by using conventional high
performance liquid chromatography (HPLC) as well. Consistently,
the fluorescence intensity of a non-functional TH/CAT-2::GFP
fusion protein [23,24] in day 2 adult haSyn expressing worms was
significantly elevated (Figure 3B).
Abnormal dopamine metabolism may produce cytotoxic
molecules such as hydrogen peroxide, superoxide radicals and
dopamine-quinone through two pathways, namely auto-oxidation
and deamination by monoamine oxidase (MO). Dopamine
deamination also yields 3,4-dihydroxyphenylacetic acid (DOPAC),
a non-toxic metabolite that can be used to monitor dopamine
deamination-specific oxidative stress [12,30].
We found that haSyn-expressing worms displayed an age-
related accumulation of DOPAC leading to a significantly higher
DOPAC content than control worms (Figure 3C), thereby
providing evidence for an haSyn-mediated disruption of dopa-
mine metabolism. Dopamine-quinone was not detected in any
worms (data not shown), possibly because dopamine auto-
oxidation is negligible in vivo. This quinone can be oxidized to
several other species [30] or become adducted to glutathione and/
or thiol groups of native proteins [31]. Nevertheless, we conclude
that haSyn expression alters dopamine metabolism in worms.
haSyn Expression Redistributes Dopamine Synaptic
Vesicles
Dopamine is loaded into synaptic vesicles by a VMAT and
pathogenic a-synuclein impairs dopamine storage in mammalian
cell lines [32,33]. To further investigate whether haSyn expression
affects dopamine homeostasis in worms, we crossed our haSyn
expressing line with a worm line expressing CAT-1::GFP [34].
CAT-1 is the sole worm homolog of VMAT. In worms expressing
only VMAT/CAT-1::GFP but not haSyn, the observed VMAT/
CAT-1::GFP expression pattern of DAergic neurites was contin-
uously linear with a few bright spots at both L2 (Figure 4A) and L4
(Figure 4E–G) stages, a finding consistent with previous reports
[34–36]. In contrast, many bright VMAT/CAT-1::GFP spots
appeared in the remarkably weakened linear fluorescent DAergic
neurites of haSyn expressing L2 worms (Figure 4C). Such an
haSyn mediated alteration of VMAT/CAT-1::GFP distribution
further developed, and VMAT/CAT-1::GFP fluorescence of
DAergic neurites was only located in discrete punctate spots
without visible lines in L4 worms (Figure 4I–M), which was prior
to the obvious start of DAergic neuron degeneration in this worm
variant.
Also consistent with previous reports [34–36], VMAT/CAT-
1::GFP in DAergic somas of control worms was excluded from the
nucleus and formed a punctate pattern in both DAergic and
serotonergic neuron somas (Figure 4B and H). haSyn expression
disrupted this pattern of VMAT/CAT-1::GFP expression exclu-
sively in DAergic but not serotonergic neurons as early as L2
(Figure 4D, L–M). From this evidence, we conclude that haSyn
expression causes dopamine synaptic vesicle maldistribution.
Disruption of haSyn-Mediated Dopamine Homeostasis
Contributes to DAergic Neuron Degeneration
The next step was to determine whether haSyn-mediated
disruption of dopamine homeostasis contributes to DAergic
neuron degeneration in worms. In rodents, exogenous expression
of DAT-1, a dopamine transporter, leads to neuronal degenera-
tion. In worms, overexpression of TH/CAT-2 produces DAergic
neuron (CEP) abnormalities [22]. Here, we found that haSyn
induced DAergic neuron degeneration more slowly in worms with
a cat-2 mutant background (Figure 5), indicating that haSyn-
mediated DAergic neuron degeneration is related to dopamine
homeostasis.
Dopamine is toxic in the cytosol but not in synaptic vesicles
[1,2,37]. Consistently, we found that VMAT/CAT-1 knockout
worms displayed slightly faster rates of DAergic neuron degener-
ation than controls (Figure 6A). If haSyn-mediated altered
dopamine metabolism contributes to haSyn-mediated dopamine
neuron degeneration, one would expect that in vivo overexpression
of VMAT/CAT-1 would ameliorate haSyn mediated DAergic
neuron degeneration. Indeed, we found that VMAT/CAT-1
Figure 2. haSyn expression leads to a motor deficit. Locomotion
speed was quantified in day 2 adult worms. **: p,0.01 (one way
ANOVA with Dunnet’s post-hoc test). n varies 10 to 15. Error bars
indicate SEM. This deficit was not observed after addition of 1 mM DA.
doi:10.1371/journal.pone.0009312.g002
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overexpression [34,38] did prevent the haSyn-mediated DAergic
neuron degeneration (Figure 6B) and motor activity deficit
(Figure 6C).
Critically, VMAT/CAT-1 overexpression prohibited haSyn-
mediated [DOPAC] upregulation (Figure 6E), but not [dopamine]
upregulation (Figure 6D), providing evidence that enhanced
sequestration of dopamine protects DAergic neurons from the
toxicity of haSyn expression by affecting dopamine turnover.
Thus, haSyn-mediated disruption of dopamine homeostasis
significantly contributes to the observed DAergic neuron degen-
eration and loss of motor activity. Consistent with this conclusion,
haSyn expression disturbed the VMAT/CAT-1::GFP expression
pattern in L2 organisms before significant DAergic neuron
degeneration starts (Figures 4 and 6B), and this disruption
persisted in the cat-2 mutant background (Figure S5), wherein
DAergic neuron degeneration was prevented.
Discussion
Using in vitro and ex vivo mammalian or drosophila cell cultures,
a-synuclein was found to disrupt dopamine homeostasis. Here, we
provide in vivo evidence to support a critical relationship between
a-synuclein and dopamine homeostasis. a-Synuclein may regulate
dopamine homeostasis through multiple mechanisms [13], such as
dopamine synthesis/breakdown [39,40], compartmentalization
[41] and recycling [42]. Consistently, we found that a-synuclein
expression altered the expression of CAT-2/TH and distribution
of dopamine synaptic vesicles.
Why did we observe an haSyn mediated dopamine functional
deficit along with upregulated dopamine synthesis and content?
One possibility to explain this paradox is that haSyn alters
dopamine synaptic vesicle trafficking or packing, which may
reduce the availability of dopamine synaptic vesicles at synapses
and stimulate dopamine synthesis through feedback control
mechanisms [43,44]. Insufficient loading of unregulated dopamine
into vesicles, therefore, could result in the observed altered
dopamine metabolism. Indeed, a-synuclein was proposed to
intervene directly in dopamine synaptic loading in mammals
[12,32,33]. But this possibility should be further explored and
validated with mammalian models.
In a previous study, investigators observed that heterological
haSyn expression in worm DAergic neurons induced dopamine
deficiency rather than upregulation [21]. Interestingly, haSyn
expression did not cause degeneration of DAergic somas in their
Figure 3. haSyn expression leads to altered dopamine metabolism. A, Quantification of dopamine content in worms with (squares) or
without (diamonds) haSyn expression is shown as a function of age. Error bars represent the SEM of 3 independent experiments. Each experiment
was done with ,200 worms per sample. B, Quantification of CAT-2::GFP florescence in DAergic neurons of EM641 worms (a worm line expressing a
non-functional CAT-2::GFP) either with (black bars) or without (gray bars) haSyn expression. ** p,0.01 (t-test). n varied from 9 to 12. Error bar, SEM. C,
Quantification of DOPAC content in haSyn expressing (squares) or control (circles) worms. Error bars represent the SEM of 3 independent
experiments. Each experiment was done with ,400 worms per sample.
doi:10.1371/journal.pone.0009312.g003
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worm lines either. The less severe cytotoxicity of haSyn in their
worm line, compared with our haSyn expressing lines and a line
reported by Caldwell’s group [22], may be due to different levels of
protein expression.
It is worthy to point out that knockout of TH/CAT-2 or
overexpression of VMAT/CAT-1 did not completely protect
DAergic neurons from haSyn-mediated degeneration. Consistent-
ly, the effect of knocking out VMAT/CAT-1 on DAergic
degeneration was not as pronounced as that resulting from haSyn
expression, indicating that haSyn-mediated cytotoxicity is not
solely caused by the disruption of dopamine homeostasis. Indeed,
a-synuclein mediated modification of chaperone-mediated au-
tophagy (CMA) also plays a critical role in DAergic neuron loss in
mammals [45].
Materials and Methods
C. elegans Strains
The promoter of dat-1 was cloned and linked to a full-length
cDNA encoding haSyn, DsRed or GFP according to a previous
Figure 4. haSyn expression disrupts dopamine synaptic vesicle distribution. A–L, Typical confocal laser scanning VMAT/CAT-1::GFP (A–D,
F–H, J–L) or bright field (E, I) images of living L2 (A–D) or L4 (E–L) nuls26 (a worm line expressing VMAT-CAT-1::GFP) worms expressing (C–D, I–L) or
not expressing (A–B, E–H) haSyn. A–D, are GFP images that show DAergic (CEP, specifically) dendrites (A, C) or DAergic/serotonergic somas (B, D) of
L2 worms. G and K are magnified areas of F and J, respectively, that show DAergic dendrites (CEP) of L4 worms. H and L, are magnified areas of F and
J, respectively, that show DAergic and serotonergic somas of L4 worms. M, Quantification of CAT-1::GFP redistribution in DAergic neurons (CEP) and
serotonergic neurons (AIM and ADF) of L2 (black bars, n = 5) and L4 worms (gray bars, n = 8). ***: p,0.0001 (t-test). Error bars indicate SEM.
doi:10.1371/journal.pone.0009312.g004
Dopamine Homeostasis in Worms
PLoS ONE | www.plosone.org 5 February 2010 | Volume 5 | Issue 2 | e9312
description [21]. Transgenic lines expressing haSyn were
generated by injecting constructs of haSyn (10 ng/ml per
injection), DsRed or GFP under the control of the dat-1 (encoding
dopamine transporter) promoter sequence [46]. Two transgenic
lines expressing haSyn were obtained and both exhibited similar
haSyn toxicity. After the transgenic line expressing haSyn was
integrated, this integrated line was backcrossed 46with wild type
worms. To produce lines expressing both haSyn and CAT-1::GFP
or CAT-2::GFP, the transgenic haSyn expressing worm line was
crossed into nuls26 or EM641, respectively [24,34]. All other
worm protocols involved standard methods [47]. cat-1 and cat-2
mutants used were e1111 and e1112, respectively. N2 was used as
the wild type.
Immunochemistry
Worms were fixed with formaldehyde and stained with goat
anti-haSyn antibody according to published protocols with slight
modifications [48]. All antibodies were purchased from Millipore.
Microscopy
All confocal experiments were conducted with a Leica TCS SP2
confocal microscope. The spectra used were: DsRed(lex = 543nm
and lem = 580–630nm) and GFP(lex = 488nm and lem = 510–
530nm). To count fluorescent DAergic neuron numbers, living
worms were immobilized with 30 mM sodium azide on 5%
agarose pads and examined with a Leica DMI3000 microscope or
a Leica TCS SP2 confocal microscope according to a published
method with modifications [21]. Specifically, fluorescent DAergic
neurons numbers were counted manually. The existence of a
fluorescent DAergic soma was evaluated by its fluorescence
intensity, its position in animals and the position of its dendrites
of a candidate neuron. The position of a neuron in worms and the
position of its dendrites are relatively unchanged in worms
throughout their life [49]. To obtain consistent data, an observer
was warmed up with 10–20 day 1 animals from an integrated wild
type line expressing DsRed in DAergic neurons, every day when
such an experiment was conducted. These animals have eight
fluorescent DAergic somas. In these experiments, representative
images were captured with an Andor iXonEM 885 EMCCD
camera and SimImaging (Feng, Z. unpublished software) (when
Lecica DMI3000 microscope was used) or a Leica TCS SP2
confocal microscope. All images were processed and analyzed with
National Instruments Vision Assistant 7.1.
Behavioral Analyses
Worm basal/enhanced slowing responses with and without
dopamine pretreatment were obtained as previously described
[21,25]. Locomotion speed was collected by using Automated and
Quantitative Analysis of Behavior of Nematode (AQUABN) with a
protocol described previously [26,27]. After a 10-minute video was
collected, the average speed from minutes 7–10 was computed to
eliminate the locomotion acclimation phase. For dopamine rescue
experiments, dopamine was added to the liquid medium before
pouring Nematode Growth Medium (NGM) plates. Animals were
then raised and experiments were conducted on dopamine
containing NGM plates. These dopamine-exposed, haSyn-
expressing animals exhibited DAergic neurite and soma degener-
ation phenotypes similar to haSyn expressing animals raised on
regular NGM plates (data not shown).
Dopamine and DOPAC Measurements
Samples were prepared as described [21] and filtered with a
0.45 mm Millipore filter before being injected into tandem LC-MS
that employed an ESI probe in the positive ion mode. The column
used was a C18 Discovery HS (5mm narrow bore), 15 cm long
with a 2.1 mm diameter. The mobile phase used for elution was
composed of solvent A (10 mM ammonium formate, pH 3.0) and
solvent B (acetonitrile) with ratios ranging from 97% – 80% of
solvent A. The detector was set up for single ion monitoring m/z
150–210.
Statistical Analysis
Statistical significance was analyzed by using Statistica (StatSoft,
Inc.). T-tests, ANOVA with Bonferroni corrections or Dunnet’s
post-hoc analyses were used for their appropriate applications.
Supporting Information
Figure S1 Immunohistochemical analysis of haSyn expression
in transgenic C. elegans. A–D, Confocal images of a formaldehyde-
fixed day 2 adult worm with DAergic neuron specific expression of
haSyn and DsRed. A, Bright field (BF). B, DsRed. C, haSyn
immunostaining (green). D. Merged image of B and C.
Found at: doi:10.1371/journal.pone.0009312.s001 (0.80 MB TIF)
Figure S2 Immunohistochemical analysis of TH expression in
transgenic C. elegans. A–B, Confocal images of formaldehyde-fixed
day 0 (A) or day 10 (B) worm with DAergic neuron specific
expression of haSyn and DsRed. Left, TH immuostaining;
Middle, DsRed; Right, Merged image of TH staining and DsRed;
C, Quantification of DAergic neuron degeneration by using TH
staining (green) or DsRed (Red). Data represents mean 6 S.E.M.,
n = 10. 1 represents 6.8 and 6.3 DAergic neurons in DsRed and
TH staining experiments, representatively.
Found at: doi:10.1371/journal.pone.0009312.s002 (0.69 MB TIF)
Figure S3 Correlation of DAergic neuron degeneration with
CAT-2::GFP and DsRed. A–B, Confocal images of living day 0
(A) or day 10 worms (B) with DAergic neuron specific expression
of CAT-2::GFP, DsRed and haSyn. Left, CAT-2::GFP; Middle,
Figure 5. Knockout of TH protects DAergic neurons from haSyn
expression toxicity. A. Quantification of fluorescent DAergic neurons
in haSyn expressing wild type (squares) or haSyn expressing TH/CAT-2
KO (diamonds) worms and in control wild type (triangles) or TH/CAT-2
KO (circles) worms. Error bars represent the SEM of three independent
experiments. **, p,0.01; ***, p,0.005 (Two-way ANOVA). In each
experiment, n of each sample varied from 10 to 30.
doi:10.1371/journal.pone.0009312.g005
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DsRed; Right, Merged image of CAT-2::GFP and DsRed. (C)
Quantification of DAergic neuron degeneration by using CAT-
2::GFP (green) or DsRed (red) in haSyn-expressing (diamonds)
and control (circles) lines. Data represent mean 6 S.E.M., n = 30.
Error bars may hide in symbols. ***, p,0.005 (Two-way ANOVA
to compare haSyn expressing and control line) (green: CAT-
2::GFP; Red DsRed). 1 represents 7.9 and 7.7 in DsRed and
CAT-2/TH::GFP experiments, respectively.
Found at: doi:10.1371/journal.pone.0009312.s003 (1.44 MB TIF)
Figure S4 haSyn expression does not affect serotonin neuro-
transmission. Enhanced slowing responses of day 2 adult worms.
GFP indicates a wild type worm line expressing GFP in DAergic
neurons. Food response experiments were conducted with (grey
bars) or without (black bars) food.
Found at: doi:10.1371/journal.pone.0009312.s004 (0.23 MB TIF)
Figure S5 haSyn expression disrupts dopamine synaptic vesicle
distribution in TH/CAT-2 knockout background. A–D, Typical
bright field (A) or confocal laser scanning VMAT/CAT-1::GFP
(B–D) images of living L2 worms expressing both VMAT/CAT-
1::GFP and haSyn in a TH/CAT-2 knockout background. C and
D are magnified areas of B that show DAergic and serotonergic
somas (C) or DAergic dendrites of CEPs (D), respectively. E,
Quantification of CAT-1::GFP redistribution in CEPs of L2
worms expressing both VMAT/CAT-1::GFP and haSyn in wild
type (n = 5) or a TH/CAT-2 knockout background (n = 5). Error
bar:SEM.
Found at: doi:10.1371/journal.pone.0009312.s005 (0.98 MB TIF)
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